Molecular Weight: 401.91 g/mol
It slows digestion, which can change how the body absorbs oral medicines
Obesity, Weight Gain, and the Risk of Kidney Stones
In our future work, we will examine the comparative effectiveness of alternative treatment options for obesity in patients who discontinue semaglutide or tirzepatide, to help patients and their clinicians make informed decisions. Reference: Obesity Treatments and Weight Changes in Clinical Practice After Discontinuation of Semaglutide or Tirzepatide by Hamlet Gasoyan, Rebecca Schulte, Christopher B
It stands for C onstant C urrent / C onstant V oltage
Unlike traditional GLP1 receptor agonists, tirzepatide is more selective for the GIP receptor, resulting in a more balanced activation of these receptors